Silvia Melgar


  • 1995                BSc in Molecular Biology, Umeå University, Umeå, Sweden
  • 2002                PhD in Immunology, Umeå University, Umeå, Sweden


Research Interests

  • Novel molecular mechanisms associated to host (immune and non-immune cells) and bacteria interactions and their relevance in health and to intestinal disorders such as inflammatory bowel disease (IBD), colorectal cancer.
  • Contribution of the immune system, environmental stimuli (such as stress and diet) and the microbiota to intestinal health and disease development in experimental models of inflammation and its translation to human diseases.
  • Pre-clinical evaluation in animal models and in in vitro systems of novel therapies for inflammatory and malignant conditions.


Please see

Professional Activity

  • 2013 – present  Senior Research Co-ordinator, APC Microbiome Institute, UCC, Ireland
  • 2012 – 2013      Senior Research Fellow, Alimentary Pharmabiotic Centre, UCC, Ireland
  • 2008 – 2012      Principal Scientist, GlaxoSmithKline, based in APC/UCC, Ireland
  • 2005 – 2007      Senior Research Scientist AZ R&D, Sweden
  • 2002 – 2005     Post-doctoral Research Fellow AstraZeneca (AZ) R&D, Sweden
  • 1995 – 2002     PhD student, Dept Immunology, Umeå University, Umeå, Sweden



Silvia Melgar

Contact Details:


Funded Investigators

APC Microbiome Ireland

Biosciences Building, University College Cork, Ireland,